RSLS stock forecast
Our latest prediction for ReShape Lifesciences Inc.'s stock price was made on the July 6, 2023 when the stock price was at 1.42$.
In the short term (2weeks), RSLS's stock price should underperform the market by -1.49%. During that period the price should oscillate between -11.98% and +11.79%.
In the medium term (3months), RSLS's stock price should outperform the market by 5.62%. During that period the price should oscillate between -35.44% and +29.56%.
Get email alertsCreate a solid portfolio with RSLS
About ReShape Lifesciences Inc.
reshape medical is a development-stage medical device manufacturer headquartered in southern california. the company is focused on the development of non-surgical weight loss devices that can be used as aids in the treatment of obese or overweight patients. there are millions of people looking for a solution to assist them in their battle to lose weight, but many are afraid of the risks of surgery. previously, few if any options existed between drugs for weight loss and invasive surgical restructuring of the anatomy. reshape medical intends to broaden the options and is developing less invasive devices for weight loss treatment.
At the moment the company generates 44M USD in revenues.
On its last earning announcement, the company reported a loss of -110.02$ per share.
The book value per share is 0.64$
Three months stock forecastJuly 6, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
44M | 15.41% | -43M | -98.66% | -40M | -110.02 | - | - | 2M | 0.64 | - | - | - |